RGEBX
Price
$74.40
Change
-$0.23 (-0.31%)
Updated
Nov 4 closing price
SOPVX
Price
$54.18
Change
+$0.03 (+0.06%)
Updated
Nov 4 closing price
Ad is loading...

RGEBX vs SOPVX

Header iconRGEBX vs SOPVX Comparison
Open Charts RGEBX vs SOPVXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$74.40
Change-$0.23 (-0.31%)
VolumeN/A
CapitalizationN/A
Allspring Opportunity A
Price$54.18
Change+$0.03 (+0.06%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RGEBX vs SOPVX Comparison Chart
Loading...
VS
RGEBX vs. SOPVX commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a StrongBuy and SOPVX is a Buy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 291B vs. SOPVX (1.95B). RGEBX pays higher dividends than SOPVX: RGEBX (0.16) vs SOPVX (0.00). RGEBX was incepted earlier than SOPVX: RGEBX (10 years) vs SOPVX (25 years). RGEBX is a more actively managed with annual turnover of: 31.00 vs. SOPVX (26.00). RGEBX has a lower initial minimum investment than SOPVX: RGEBX (250) vs SOPVX (1000). RGEBX annual gain was more profitable for investors over the last year : 28.39 vs. SOPVX (24.24). RGEBX return over 5 years is better than : 48.56 vs. SOPVX (22.71).
RGEBXSOPVXRGEBX / SOPVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years25 years-
Gain YTD22.24813.063170%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets291B1.95B14,931%
Annual Yield % from dividends0.160.00-
Returns for 1 year28.3924.24117%
Returns for 3 years-8.65-11.7773%
Returns for 5 years48.5622.71214%
Returns for 10 years60.897.31833%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANTX1.08N/A
N/A
AN2 Therapeutics
ZURA4.38N/A
N/A
Zura Bio Limited
CLMT21.02-0.10
-0.47%
Calumet Inc.
ACGL95.00-1.02
-1.06%
Arch Capital Group Ltd
ADMA19.11-0.26
-1.34%
ADMA Biologics